Medicines / Sanofi India / Apidra
ApidraGlulisine
Apidra is marketed by Sanofi India. 3 packs on NPPA's price list for July 2026, containing Glulisine.
- Packs listed
- 3
- Lowest MRP
- ₹920.68
- Per unit
- ₹185.50 to ₹390.00
- Price-controlled packs
- 0 of 3
- Dosage forms
- 2
Packs and prices
- ₹920.68Apidra 100 iu Cartridge 3 mlGlulisine Cartridge 100 iu · ₹306.89 per ml
- ₹1,855Apidra 100 iu Injection 10 mlGlulisine Injection 100 iu · ₹185.50 per ml
- ₹1,170Apidra Solostar 300 iu Injection 3 mlGlulisine Injection 300 iu · ₹390.00 per ml
The company
Sanofi India has 95 packs on the price list, and CDSCO has named it as the manufacturer of 8 failed batches since Feb 2016. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.